Dr. Doucette, Dr. Dolinsky, and Dr. Hatch conducted a study to study the role of TAZ (Tafazzin), a cardiolipin (CL) biosynthetic enzyme important for maintaining mitochondrial function in regulating pancreatic islet function, particularly under low-glucose conditions.
CLICK HERE for the full article
What's New
All Articles
Check out the latest DREAM Newsletter!
The DREAM theme is excited to announce the release of our third newsletter! Here you will find updates from our…
Island Lake Anisininew Nations Annual General Assembly
The iCARE and Next Generation team was honoured to be invited to participate in the Island Lake Anisininew Nations Annual…
Can-SOLVE CKD’s 10th Annual Meeting
From May 7 – 9, 2026, Can-SOLVE CKD held their 10th Annual Meeting in Quebec City. Dr. Allison Dart received…
CTVNews Winnipeg Interview with Dr. Brandy Wicklow
DREAM researcher Dr. Brandy Wicklow, pediatric endocrinologist at the University of Manitoba and Children’s Hospital Research Institute of Manitoba, was…
iCARE PAG Member Antonina Kandiurin Presented at ISPAD 2025
iCARE PAG member Antonina Kandiurin presented at the 51st Annual International Society for Pediatric and Adolescent Diabetes (ISPAD) Conference held…
New publication from the Dolinsky Lab!
Congratulations to Caitlin Menzies, PhD student in Dr. Vern Dolinsky’s lab, for their newly published review in the Journal of…